AP1S1
Basic information
Region (hg38): 7:101154456-101161596
Previous symbols: [ "CLAPS1", "EKV3" ]
Links
Phenotypes
GenCC
Source:
- MEDNIK syndrome (Strong), mode of inheritance: AR
- MEDNIK syndrome (Strong), mode of inheritance: AR
- MEDNIK syndrome (Supportive), mode of inheritance: AR
- MEDNIK syndrome (Strong), mode of inheritance: AR
- MEDNIK syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
MEDNIK syndrome | AR | Audiologic/Otolaryngologic; Biochemical | As the condition may include hearing loss, recognition and interventions related to speech and language development may be beneficial; The condition involves abnormal copper metabolism, and medical management (with Zinc acetate) has been shown to be beneficial related to both lab-based as well as clinical outcomes | Audiologic/Otolaryngologic; Biochemical; Dermatologic; Neurologic | 19057675; 23423674; 23622398; 24754424 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (4 variants)
- MEDNIK syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AP1S1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 45 | 49 | ||||
missense | 9 | |||||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 15 | 15 | ||||
non coding | 33 | 14 | 47 | |||
Total | 4 | 5 | 10 | 78 | 18 |
Highest pathogenic variant AF is 0.00000657
Variants in AP1S1
This is a list of pathogenic ClinVar variants found in the AP1S1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-101154516-T-C | Uncertain significance (Nov 01, 2022) | |||
7-101154524-T-A | Likely benign (Sep 28, 2023) | |||
7-101154525-G-A | Likely benign (Jun 23, 2023) | |||
7-101154525-G-T | Likely benign (Apr 16, 2023) | |||
7-101154528-C-A | Likely benign (Mar 16, 2023) | |||
7-101154529-G-A | Likely benign (Jan 28, 2023) | |||
7-101154532-G-T | Likely benign (Jul 29, 2023) | |||
7-101154535-G-GGAGGGGAGGGGGAAGC | Likely benign (Jul 03, 2023) | |||
7-101156292-A-G | Benign (Nov 11, 2018) | |||
7-101156583-A-G | Benign (Jan 30, 2024) | |||
7-101156589-C-A | Likely benign (Apr 12, 2023) | |||
7-101156590-A-G | Likely benign (Jan 13, 2023) | |||
7-101156597-C-T | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
7-101156606-C-T | Benign (Jan 27, 2024) | |||
7-101156608-A-G | AP1S1-related disorder | Likely benign (Jan 27, 2024) | ||
7-101156630-C-T | Likely benign (Jan 20, 2024) | |||
7-101156633-C-A | Likely benign (Nov 17, 2023) | |||
7-101156650-C-G | Pathogenic (Jul 16, 2023) | |||
7-101156659-T-G | Likely benign (Aug 07, 2023) | |||
7-101156662-G-A | Likely benign (Jan 15, 2024) | |||
7-101156662-G-C | Likely benign (Nov 28, 2023) | |||
7-101156677-G-A | Likely benign (Jun 06, 2023) | |||
7-101156686-G-A | Likely benign (Jan 11, 2024) | |||
7-101156689-C-T | Benign (Jan 31, 2024) | |||
7-101156707-C-A | Likely benign (Jan 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AP1S1 | protein_coding | protein_coding | ENST00000337619 | 5 | 7200 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.100 | 0.869 | 124545 | 0 | 3 | 124548 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.74 | 41 | 86.7 | 0.473 | 0.00000495 | 1021 |
Missense in Polyphen | 12 | 34.558 | 0.34725 | 424 | ||
Synonymous | 0.401 | 33 | 36.1 | 0.915 | 0.00000213 | 277 |
Loss of Function | 1.85 | 3 | 9.00 | 0.334 | 4.42e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000365 | 0.0000266 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules. {ECO:0000269|PubMed:9733768}.;
- Disease
- DISEASE: Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma (MEDNIK) [MIM:609313]: A disorder characterized by erythematous skin lesions and hyperkeratosis, severe psychomotor retardation, peripheral neuropathy, sensorineural hearing loss, together with elevated very-long-chain fatty acids and severe congenital diarrhea. {ECO:0000269|PubMed:19057675}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Lysosome - Homo sapiens (human);Golgi Associated Vesicle Biogenesis;Lysosome Vesicle Biogenesis;Clathrin derived vesicle budding;Disease;trans-Golgi Network Vesicle Budding;Vesicle-mediated transport;Membrane Trafficking;Host Interactions of HIV factors;HIV Infection;MHC class II antigen presentation;Infectious disease;Immune System;Adaptive Immune System;Nef mediated downregulation of MHC class I complex cell surface expression;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis
(Consensus)
Recessive Scores
- pRec
- 0.138
Intolerance Scores
- loftool
- 0.611
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.2
Haploinsufficiency Scores
- pHI
- 0.281
- hipred
- Y
- hipred_score
- 0.645
- ghis
- 0.601
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.931
Mouse Genome Informatics
- Gene name
- Ap1s1
- Phenotype
Zebrafish Information Network
- Gene name
- ap1s1
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- intracellular protein transport;receptor-mediated endocytosis;response to virus;antigen processing and presentation of exogenous peptide antigen via MHC class II;retrograde transport, endosome to Golgi;regulation of defense response to virus by virus
- Cellular component
- Golgi membrane;lysosomal membrane;Golgi apparatus;cytosol;clathrin-coated pit;membrane;AP-1 adaptor complex;cytoplasmic vesicle membrane;trans-Golgi network membrane;terminal bouton;intracellular membrane-bounded organelle
- Molecular function